{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:51:59Z","timestamp":1775148719782,"version":"3.50.1"},"reference-count":88,"publisher":"American Spinal Injury Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Lower urinary tract symptoms (LUTS) are a frequent complaint after spinal cord injury and disease (SCI\/D). As such, the majority of people with upper motor neuron SCI\/D utilize medications for neurogenic detrusor overactivity (NDO), and overtreatment with systemic antimicrobials is common. Many people with SCI\/D utilize urinary catheters for bladder management. These devices offer a conduit for delivery of targeted intravesical therapeutics for both NDO and LUTS (including those due to urinary tract infection [UTI]), which have the potential for greater efficacy due to higher concentration of therapeutics and fewer systemic side effects due to limited permeability of the uroepithelium. Specifically, intravesical therapeutics have the potential to prevent and treat UTI by altering uropathogen's access to the uroepithelium, washout of bacteria, uropathogen adherence, bladder ischemia, and other possible mechanisms of infection. This article presents intravesical therapeutic options for people with neurogenic lower urinary tract dysfunction (NLUTD) due to SCI\/D, including bladder flushes and instillates of readily accessible medications and experimental agents (such as live biotherapeutics) in normal saline or sterile water. We propose that the intravesical approach to drug delivery is underutilized for people with NLUTD due to SCI\/D and offers a valuable alternative to systemic medications.<\/jats:p>","DOI":"10.46292\/sci24-00088","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:32:56Z","timestamp":1764923576000},"page":"21-29","source":"Crossref","is-referenced-by-count":0,"title":["Intravesical Therapeutics Among People With Spinal Cord Injury and Disease: Time for a Change"],"prefix":"10.46292","volume":"32","author":[{"given":"Suzanne L.","family":"Groah","sequence":"first","affiliation":[{"name":"MedStar National Rehabilitation Hospital, Washington, DC"},{"name":"Department of Rehabilitation Medicine, MedStar Georgetown University Hospital, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Valeria Aguirre","family":"Guemez","sequence":"additional","affiliation":[{"name":"MedStar National Rehabilitation Hospital, Washington, DC"},{"name":"Department of Rehabilitation Medicine, MedStar Georgetown University Hospital, Washington, DC"},{"name":"MedStar Health Research Institute, Columbia, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Solman","sequence":"additional","affiliation":[{"name":"Department of Medical Education, Florida International University Herbert Wertheim College of Medicine, Miami, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"25425","reference":[{"key":"b1","series-title":"Top Spinal Cord Inj Rehabil","first-page":"3143","article-title":"Urinary symptoms among people with neurogenic lower urinary tract dysfunction (NLUTD) vary by bladder management","volume":"29","author":"Tractenberg RE","year":"2023","unstructured":"Tractenberg RE, et al. Urinary symptoms among people with neurogenic lower urinary tract dysfunction (NLUTD) vary by bladder management. Top Spinal Cord Inj Rehabil. 2023;29:3143."},{"key":"b2","series-title":"Spinal Cord","first-page":"462467","article-title":"Neurogenic bladder in patients with traumatic spinal cord injury: Treatment and followup","volume":"52","author":"Neurogenic Bladder Turkish Research Group","year":"2014","unstructured":"Neurogenic Bladder Turkish Research Group, et al. Neurogenic bladder in patients with traumatic spinal cord injury: Treatment and followup. Spinal Cord. 2014;52:462467."},{"key":"b3","series-title":"Neurourol Urodyn","first-page":"19161923","article-title":"Effectiveness and patient perspective on the use of intravesical gentamicin instillations to treat recurrent urinary tract infections in neurogenic lower urinary tract dysfunction","volume":"43","author":"Cameron AP","year":"2024","unstructured":"Cameron AP, Castrodad PM, Troost J, Forchheimer M, Tate DG. Effectiveness and patient perspective on the use of intravesical gentamicin instillations to treat recurrent urinary tract infections in neurogenic lower urinary tract dysfunction. Neurourol Urodyn. 2024;43:19161923."},{"key":"b4","series-title":"J Drug Deliv Sci Technol","first-page":"106110","article-title":"Challenges and opportunities in intravesical drug delivery approaches for the treatment of lower urinary diseases","volume":"100","author":"Kumari P","year":"2024","unstructured":"Kumari P, Goyal AK. Challenges and opportunities in intravesical drug delivery approaches for the treatment of lower urinary diseases. J Drug Deliv Sci Technol. 2024;100:106110."},{"key":"b5","series-title":"Neurourol Urodyn","first-page":"95100","article-title":"Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: Some revered, few forgotten, others ignored: Pathogenesis of UTI in neurogenic bladders","volume":"33","author":"Vasudeva P","year":"2014","unstructured":"Vasudeva P, Madersbacher H. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: Some revered, few forgotten, others ignored: Pathogenesis of UTI in neurogenic bladders. Neurourol Urodyn. 2014;33:95100."},{"issue":"6","key":"b6","series-title":"J Clin Urol","article-title":"Intravesical gentamicin treatment for recurrent urinary tract infections: A systematic review over the last two decades","volume":"17","author":"Rutherford G","year":"2022","unstructured":"Rutherford G, et al. Intravesical gentamicin treatment for recurrent urinary tract infections: A systematic review over the last two decades. J Clin Urol. 2022;17(6). doi:10.1177\/20514158221138845."},{"key":"b7","series-title":"Neurourol Urodyn","first-page":"390399","article-title":"Is Intravesical gentamicin the new gold standard to manage refractory urinary tract infections?\u2014Experience from a dedicated multidisciplinary complex UTI clinic","volume":"44","author":"Chitteti P","year":"2025","unstructured":"Chitteti P, Ekpeno I, Morris Laverick J, Bezemer S, Nadeem M. Is Intravesical gentamicin the new gold standard to manage refractory urinary tract infections?\u2014Experience from a dedicated multidisciplinary complex UTI clinic. Neurourol Urodyn. 2025;44:390399."},{"key":"b8","series-title":"J Pediatr Urol","first-page":"64","article-title":"Intravesical gentamicin instillation in the prevention of recurrent urinary tract infections in children with neurogenic bladdera singlecenter retrospective observational study","volume":"19","author":"Mouhssine M","year":"2023","unstructured":"Mouhssine M, et al. Intravesical gentamicin instillation in the prevention of recurrent urinary tract infections in children with neurogenic bladdera singlecenter retrospective observational study. J Pediatr Urol. 2023;19:64.e164.e7."},{"key":"b9","series-title":"Antibiotics","first-page":"1335","article-title":"Intravesical gentamicin: An option for therapy and prophylaxis against recurrent UTIs and resistant bacteria in neurogenic bladder patients on intermittent catheterization","volume":"11","author":"Andretta E","year":"2022","unstructured":"Andretta E, Longo R, Balladelli M, Sgarabotto C, Sgarabotto D. Intravesical gentamicin: An option for therapy and prophylaxis against recurrent UTIs and resistant bacteria in neurogenic bladder patients on intermittent catheterization. Antibiotics. 2022;11:1335."},{"key":"b10","series-title":"Curr Urol Rep","first-page":"78","article-title":"Use and effectiveness of antimicrobial intravesical treatment for prophylaxis and treatment of recurrent urinary tract infections (UTIs): A systematic review","volume":"19","author":"Pietropaolo A","year":"2018","unstructured":"Pietropaolo A, Jones P, Moors M, Birch B, Somani BK. Use and effectiveness of antimicrobial intravesical treatment for prophylaxis and treatment of recurrent urinary tract infections (UTIs): A systematic review. Curr Urol Rep. 2018;19:78."},{"key":"b11","series-title":"J Spinal Cord Med","first-page":"965968","article-title":"Singledose intravesical amikacin instillation for pyocystis in a patient with autonomic dysreflexia: A case report","volume":"45","author":"Sherwin E","year":"2022","unstructured":"Sherwin E, King C, Hasen H, May S. Singledose intravesical amikacin instillation for pyocystis in a patient with autonomic dysreflexia: A case report. J Spinal Cord Med. 2022;45:965968."},{"key":"b12","series-title":"Spinal Cord Medicine","article-title":"Urologic management and renal disease in spinal cord injury","author":"Linsenmeyer TA","year":"2018","unstructured":"Linsenmeyer TA. Urologic management and renal disease in spinal cord injury. In Kirshblum S, Lin VW, eds., Spinal Cord Medicine. Springer; 2018. doi:10.1891\/9780826137753.0022."},{"key":"b13","series-title":"J Spinal Cord Med","first-page":"18","article-title":"A single intravesical instillation of Lactobacillus rhamnosus GG is safe in children and adults with neuropathic bladder: A phase Ia clinical trial","author":"Forster CS","year":"2019","unstructured":"Forster CS, et al. A single intravesical instillation of Lactobacillus rhamnosus GG is safe in children and adults with neuropathic bladder: A phase Ia clinical trial. J Spinal Cord Med. 2019:18. doi:10.1080\/10790268.2019.1616456."},{"key":"b14","series-title":"Ther Adv Urol","first-page":"1756287219875594","article-title":"Intravesical Lactobacillus rhamnosus GG is safe and well tolerated in adults and children with neurogenic lower urinary tract dysfunction: Firstinhuman trial","volume":"11","author":"Groah SL","year":"2019","unstructured":"Groah SL, et al. Intravesical Lactobacillus rhamnosus GG is safe and well tolerated in adults and children with neurogenic lower urinary tract dysfunction: Firstinhuman trial. Ther Adv Urol. 2019;11:1756287219875594."},{"key":"b15","series-title":"J Am Geriatr Soc","first-page":"886887","article-title":"Continuous bladder irrigation with vancomycin for the treatment of methicillin resistant Staphylococcus aureus","volume":"44","author":"Hajjar RR","year":"1996","unstructured":"Hajjar RR, Philpot C, Morley JE. Continuous bladder irrigation with vancomycin for the treatment of methicillin resistant Staphylococcus aureus. J Am Geriatr Soc. 1996;44:886887."},{"key":"b16","series-title":"J Pediatr Pharmacol Ther","first-page":"102107","article-title":"Use of intravesicular amikacin irrigations for the treatment and prophylaxis of urinary tract infections in a patient with spina bifida and neurogenic bladder: A case report","volume":"16","author":"Huynh D","year":"2011","unstructured":"Huynh D, Morgan JA. Use of intravesicular amikacin irrigations for the treatment and prophylaxis of urinary tract infections in a patient with spina bifida and neurogenic bladder: A case report. J Pediatr Pharmacol Ther. 2011;16:102107."},{"key":"b17","series-title":"Br J Urol","first-page":"367374","article-title":"The value of kanamycincolistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord injury","volume":"51","author":"Pearman JW","year":"1979","unstructured":"Pearman JW. The value of kanamycincolistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord injury. Br J Urol. 1979;51:367374."},{"key":"b18","series-title":"Transl Androl Urol","first-page":"S163S170","article-title":"Recurrent urinary tract infections in patients with incomplete bladder emptying: Is there a role for intravesical therapy?","volume":"6","author":"Dray EV","year":"2017","unstructured":"Dray EV, Clemens JQ. Recurrent urinary tract infections in patients with incomplete bladder emptying: Is there a role for intravesical therapy? Transl Androl Urol. 2017;6:S163S170."},{"key":"b19","series-title":"Pediatr Surg Int","first-page":"781785","article-title":"Efficacy of bladder irrigation and surveillance program in prevention of urinary tract infections and bladder calculi in children with an ileocystoplasty and bladder neck repair","volume":"27","author":"Van Den Heijkant M","year":"2011","unstructured":"Van Den Heijkant M, Haider N, Taylor C, Subramaniam R. Efficacy of bladder irrigation and surveillance program in prevention of urinary tract infections and bladder calculi in children with an ileocystoplasty and bladder neck repair. Pediatr Surg Int. 2011;27:781785."},{"key":"b20","series-title":"Int J Antimicrob Agents","first-page":"485490","article-title":"Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation","volume":"36","author":"van Nieuwkoop C","year":"2010","unstructured":"van Nieuwkoop C, den Exter PL, Elzevier HW, den Hartigh J, van Dissel JT. Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation. Int J Antimicrob Agents. 2010;36:485490."},{"key":"b21","series-title":"J Urol","first-page":"18611864","article-title":"Safety of gentamicin bladder irrigations in complex urological cases","volume":"175","author":"Defoor W","year":"2006","unstructured":"Defoor W, et al. Safety of gentamicin bladder irrigations in complex urological cases. J Urol. 2006;175:18611864."},{"key":"b22","series-title":"J Urol","first-page":"549555","article-title":"Intravesical gentamicin treatment for recurrent urinary tract infections caused by multidrug resistant bacteria","volume":"201","author":"Stalenhoef JE","year":"2019","unstructured":"Stalenhoef JE, et al. Intravesical gentamicin treatment for recurrent urinary tract infections caused by multidrug resistant bacteria. J Urol. 2019;201:549555."},{"key":"b23","series-title":"Intravesical Administration of Therapeutic Medication for the Treatment of Bladder Cancer","author":"Baumbartner R","year":"2020","unstructured":"Baumbartner R, Chang S, Flick S, et al. Intravesical Administration of Therapeutic Medication for the Treatment of Bladder Cancer. 2020. https:\/\/www.auanet.org\/aboutus\/auastatements\/intravesicaladministrationoftherapeuticmedication."},{"key":"b24","series-title":"Spinal Cord Medicine","author":"Kirshblum SM","year":"2018","unstructured":"Kirshblum SM, Lin VW. Spinal Cord Medicine. 3rd ed. Springer; 2018."},{"key":"b25","series-title":"Indian J Urol","first-page":"8287","article-title":"The impact of anticholinergics on cognitive function in patients with neurogenic lower urinary tract dysfunction: A narrative review","volume":"40","author":"Welk B","year":"2024","unstructured":"Welk B. The impact of anticholinergics on cognitive function in patients with neurogenic lower urinary tract dysfunction: A narrative review. Indian J Urol. 2024;40:8287."},{"key":"b26","series-title":"Spinal Cord","first-page":"854861","article-title":"Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: A systematic review","volume":"60","author":"Akkoc Y","year":"2022","unstructured":"Akkoc Y. Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: A systematic review. Spinal Cord. 2022;60:854861."},{"key":"b27","series-title":"BJU Int","first-page":"2533","article-title":"Detrusor relaxing agents for neurogenic detrusor overactivity: A systematic review, metaanalysis and network metaanalysis","volume":"133","author":"Zhou Z","year":"2024","unstructured":"Zhou Z, Wang X, Li X, Liao L. Detrusor relaxing agents for neurogenic detrusor overactivity: A systematic review, metaanalysis and network metaanalysis. BJU Int. 2024;133:2533."},{"key":"b28","series-title":"Top Spinal Cord Inj Rehabil","first-page":"4457","article-title":"Intravesical Lactobacillus rhamnosus GG alters urobiome composition and diversity among people with neurogenic lower urinary tract dysfunction","volume":"29","author":"Groah SL","year":"2023","unstructured":"Groah SL, Rounds AK, P\u00e9rezLosada M. Intravesical Lactobacillus rhamnosus GG alters urobiome composition and diversity among people with neurogenic lower urinary tract dysfunction. Top Spinal Cord Inj Rehabil. 2023;29:4457."},{"key":"b29","series-title":"PM R","first-page":"229240","article-title":"Clinical profiles and symptom burden estimates to support decisionmaking using the urinary symptom questionnaire for people with neurogenic bladder (USQNB) using intermittent catheters","volume":"13","author":"Tractenberg RE","year":"2020","unstructured":"Tractenberg RE, et al. Clinical profiles and symptom burden estimates to support decisionmaking using the urinary symptom questionnaire for people with neurogenic bladder (USQNB) using intermittent catheters. PM R. 2020;13:229240."},{"issue":"7","key":"b30","series-title":"PM R","first-page":"695706","article-title":"Effects of intravesical Lactobacillus rhamnosus GG on urinary symptom burden in people with neurogenic lower urinary tract dysfunction","volume":"13","author":"Tractenberg RE","year":"2021","unstructured":"Tractenberg RE, et al. Effects of intravesical Lactobacillus rhamnosus GG on urinary symptom burden in people with neurogenic lower urinary tract dysfunction. PM R. 2021;13(7):695706. doi:10.1002\/pmrj.12470."},{"issue":"19","key":"b31","series-title":"J Bacteriol","article-title":"Phenyllactic acid is an active ingredientin bactericidal supernatants of Lactobacillus crispatus","volume":"203","author":"AbdulRahim O","year":"2021","unstructured":"AbdulRahim O, et al. Phenyllactic acid is an active ingredientin bactericidal supernatants of Lactobacillus crispatus. J Bacteriol. 2021;203(19):e0036021. doi:10.1128\/JB.0036021."},{"key":"b32","series-title":"Ther Adv Urol","first-page":"9199","article-title":"Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: An update on the evidence","volume":"8","author":"Lazzeri M","year":"2016","unstructured":"Lazzeri M, et al. Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: An update on the evidence. Ther Adv Urol. 2016;8:9199."},{"key":"b33","series-title":"J Spinal Cord Med","first-page":"830836","article-title":"Intravesical hyaluronic acid with chondroitin sulphate to prevent urinary tract infection after spinal cord injury","volume":"46","author":"King GK","year":"2023","unstructured":"King GK, et al. Intravesical hyaluronic acid with chondroitin sulphate to prevent urinary tract infection after spinal cord injury. J Spinal Cord Med. 2023;46:830836."},{"key":"b34","series-title":"Urology","first-page":"e48e57","article-title":"Current status of intravesical therapies for bladder pain syndrome (BPS): A narrative review of emerging evidence","volume":"156","author":"Jones P","year":"2021","unstructured":"Jones P, et al. Current status of intravesical therapies for bladder pain syndrome (BPS): A narrative review of emerging evidence. Urology. 2021;156:e48e57."},{"issue":"1960","key":"b35","series-title":"J Obstet Gynaecol Br Emp","first-page":"394401","article-title":"Urinary infection after colporrhaphy: Its incidence, causation and prevention","volume":"67","author":"Paterson ML","year":"1960","unstructured":"Paterson ML, Barr W, Macdonald S. Urinary infection after colporrhaphy: Its incidence, causation and prevention. J Obstet Gynaecol Br Emp. 1960;67:394401 (1960)."},{"key":"b36","series-title":"J Rehabil Med","first-page":"181184","article-title":"Bladder irrigation with Chlorhexidine reduces bacteriuria in persons with spinal cord injury","volume":"50","author":"Wikstr\u00f6m M","year":"2018","unstructured":"Wikstr\u00f6m M, Levi R, Antepohl W. Bladder irrigation with Chlorhexidine reduces bacteriuria in persons with spinal cord injury. J Rehabil Med. 2018;50:181184."},{"key":"b37","series-title":"Neurourol Urodyn","first-page":"6782","article-title":"Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta analysis. A report from the Neuro Urology Promotion Committee of the International Continence Society (ICS)","volume":"37","author":"Ph\u00e9 V","year":"2018","unstructured":"Ph\u00e9 V, et al. Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta analysis. A report from the Neuro Urology Promotion Committee of the International Continence Society (ICS). Neurourol Urodyn. 2018;37:6782."},{"key":"b38","series-title":"J Pediatr Urol","first-page":"366","article-title":"Intravesical hyaluronic acid treatment in recurrent urinary tract infections in children with spina bifida and neurogenic bladder","volume":"16","author":"Cicek N","year":"2020","unstructured":"Cicek N, Yildiz N, Alpay H. Intravesical hyaluronic acid treatment in recurrent urinary tract infections in children with spina bifida and neurogenic bladder. J Pediatr Urol. 2020;16:366.e1366.e5."},{"key":"b39","series-title":"Bladder Pain Syndrome","first-page":"307315","article-title":"Intravesical therapy","author":"Cervigni M","year":"2013","unstructured":"Cervigni M, Van Ophoven A. Intravesical therapy. In Nordling J, ed. Bladder Pain Syndrome. Springer; 2013:307315. doi:10.1007\/9781441969293_23."},{"key":"b40","series-title":"J Clin Med Res","first-page":"256260","article-title":"Longterm efficacy, safety, and tolerability of modified intravesical oxybutynin chloride for neurogenic bladder in children","volume":"11","author":"Honda M","year":"2019","unstructured":"Honda M, et al. Longterm efficacy, safety, and tolerability of modified intravesical oxybutynin chloride for neurogenic bladder in children. J Clin Med Res. 2019;11:256260."},{"key":"b41","series-title":"Int Urol Nephrol","first-page":"737747","article-title":"Intravesical oxybutynin therapy for patients with neurogenic detrusor overactivity: A systematic review and metaanalysis","volume":"54","author":"Shen S","year":"2022","unstructured":"Shen S, et al. Intravesical oxybutynin therapy for patients with neurogenic detrusor overactivity: A systematic review and metaanalysis. Int Urol Nephrol. 2022;54:737747."},{"key":"b42","series-title":"J Spinal Cord Med","first-page":"S6788","article-title":"Acute management of autonomic dysreflexia: Individuals with spinal cord injury presenting to healthcare facilities","volume":"25","author":"Consortium for Spinal Cord Medicine","year":"2002","unstructured":"Consortium for Spinal Cord Medicine. Acute management of autonomic dysreflexia: Individuals with spinal cord injury presenting to healthcare facilities. J Spinal Cord Med. 2002;25)Suppl 1): S6788."},{"key":"b43","series-title":"Br J Urol","first-page":"504507","article-title":"Treatment of interstitial cystitis with intravesical heparin","volume":"73","author":"Parsons CL","year":"1994","unstructured":"Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br J Urol. 1994;73:504507."},{"key":"b44","series-title":"J Formos Med Assoc","first-page":"309314","article-title":"Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis","volume":"100","author":"Kuo HC","year":"2001","unstructured":"Kuo HC. Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis. J Formos Med Assoc. 2001;100:309314."},{"key":"b1","series-title":"Top Spinal Cord Inj Rehabil","first-page":"3143","article-title":"Urinary symptoms among people with neurogenic lower urinary tract dysfunction (NLUTD) vary by bladder management","volume":"29","author":"Tractenberg RE","year":"2023","unstructured":"Tractenberg RE, et al. Urinary symptoms among people with neurogenic lower urinary tract dysfunction (NLUTD) vary by bladder management. Top Spinal Cord Inj Rehabil. 2023;29:3143."},{"key":"b2","series-title":"Spinal Cord","first-page":"462467","article-title":"Neurogenic bladder in patients with traumatic spinal cord injury: Treatment and followup","volume":"52","author":"Neurogenic Bladder Turkish Research Group","year":"2014","unstructured":"Neurogenic Bladder Turkish Research Group, et al. Neurogenic bladder in patients with traumatic spinal cord injury: Treatment and followup. Spinal Cord. 2014;52:462467."},{"key":"b3","series-title":"Neurourol Urodyn","first-page":"19161923","article-title":"Effectiveness and patient perspective on the use of intravesical gentamicin instillations to treat recurrent urinary tract infections in neurogenic lower urinary tract dysfunction","volume":"43","author":"Cameron AP","year":"2024","unstructured":"Cameron AP, Castrodad PM, Troost J, Forchheimer M, Tate DG. Effectiveness and patient perspective on the use of intravesical gentamicin instillations to treat recurrent urinary tract infections in neurogenic lower urinary tract dysfunction. Neurourol Urodyn. 2024;43:19161923."},{"key":"b4","series-title":"J Drug Deliv Sci Technol","first-page":"106110","article-title":"Challenges and opportunities in intravesical drug delivery approaches for the treatment of lower urinary diseases","volume":"100","author":"Kumari P","year":"2024","unstructured":"Kumari P, Goyal AK. Challenges and opportunities in intravesical drug delivery approaches for the treatment of lower urinary diseases. J Drug Deliv Sci Technol. 2024;100:106110."},{"key":"b5","series-title":"Neurourol Urodyn","first-page":"95100","article-title":"Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: Some revered, few forgotten, others ignored: Pathogenesis of UTI in neurogenic bladders","volume":"33","author":"Vasudeva P","year":"2014","unstructured":"Vasudeva P, Madersbacher H. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: Some revered, few forgotten, others ignored: Pathogenesis of UTI in neurogenic bladders. Neurourol Urodyn. 2014;33:95100."},{"issue":"6","key":"b6","series-title":"J Clin Urol","article-title":"Intravesical gentamicin treatment for recurrent urinary tract infections: A systematic review over the last two decades","volume":"17","author":"Rutherford G","year":"2022","unstructured":"Rutherford G, et al. Intravesical gentamicin treatment for recurrent urinary tract infections: A systematic review over the last two decades. J Clin Urol. 2022;17(6). doi:10.1177\/20514158221138845."},{"key":"b7","series-title":"Neurourol Urodyn","first-page":"390399","article-title":"Is Intravesical gentamicin the new gold standard to manage refractory urinary tract infections?\u2014Experience from a dedicated multidisciplinary complex UTI clinic","volume":"44","author":"Chitteti P","year":"2025","unstructured":"Chitteti P, Ekpeno I, Morris Laverick J, Bezemer S, Nadeem M. Is Intravesical gentamicin the new gold standard to manage refractory urinary tract infections?\u2014Experience from a dedicated multidisciplinary complex UTI clinic. Neurourol Urodyn. 2025;44:390399."},{"key":"b8","series-title":"J Pediatr Urol","first-page":"64","article-title":"Intravesical gentamicin instillation in the prevention of recurrent urinary tract infections in children with neurogenic bladdera singlecenter retrospective observational study","volume":"19","author":"Mouhssine M","year":"2023","unstructured":"Mouhssine M, et al. Intravesical gentamicin instillation in the prevention of recurrent urinary tract infections in children with neurogenic bladdera singlecenter retrospective observational study. J Pediatr Urol. 2023;19:64.e164.e7."},{"key":"b9","series-title":"Antibiotics","first-page":"1335","article-title":"Intravesical gentamicin: An option for therapy and prophylaxis against recurrent UTIs and resistant bacteria in neurogenic bladder patients on intermittent catheterization","volume":"11","author":"Andretta E","year":"2022","unstructured":"Andretta E, Longo R, Balladelli M, Sgarabotto C, Sgarabotto D. Intravesical gentamicin: An option for therapy and prophylaxis against recurrent UTIs and resistant bacteria in neurogenic bladder patients on intermittent catheterization. Antibiotics. 2022;11:1335."},{"key":"b10","series-title":"Curr Urol Rep","first-page":"78","article-title":"Use and effectiveness of antimicrobial intravesical treatment for prophylaxis and treatment of recurrent urinary tract infections (UTIs): A systematic review","volume":"19","author":"Pietropaolo A","year":"2018","unstructured":"Pietropaolo A, Jones P, Moors M, Birch B, Somani BK. Use and effectiveness of antimicrobial intravesical treatment for prophylaxis and treatment of recurrent urinary tract infections (UTIs): A systematic review. Curr Urol Rep. 2018;19:78."},{"key":"b11","series-title":"J Spinal Cord Med","first-page":"965968","article-title":"Singledose intravesical amikacin instillation for pyocystis in a patient with autonomic dysreflexia: A case report","volume":"45","author":"Sherwin E","year":"2022","unstructured":"Sherwin E, King C, Hasen H, May S. Singledose intravesical amikacin instillation for pyocystis in a patient with autonomic dysreflexia: A case report. J Spinal Cord Med. 2022;45:965968."},{"key":"b12","series-title":"Spinal Cord Medicine","article-title":"Urologic management and renal disease in spinal cord injury","author":"Linsenmeyer TA","year":"2018","unstructured":"Linsenmeyer TA. Urologic management and renal disease in spinal cord injury. In Kirshblum S, Lin VW, eds., Spinal Cord Medicine. Springer; 2018. doi:10.1891\/9780826137753.0022."},{"key":"b13","series-title":"J Spinal Cord Med","first-page":"18","article-title":"A single intravesical instillation of Lactobacillus rhamnosus GG is safe in children and adults with neuropathic bladder: A phase Ia clinical trial","author":"Forster CS","year":"2019","unstructured":"Forster CS, et al. A single intravesical instillation of Lactobacillus rhamnosus GG is safe in children and adults with neuropathic bladder: A phase Ia clinical trial. J Spinal Cord Med. 2019:18. doi:10.1080\/10790268.2019.1616456."},{"key":"b14","series-title":"Ther Adv Urol","first-page":"1756287219875594","article-title":"Intravesical Lactobacillus rhamnosus GG is safe and well tolerated in adults and children with neurogenic lower urinary tract dysfunction: Firstinhuman trial","volume":"11","author":"Groah SL","year":"2019","unstructured":"Groah SL, et al. Intravesical Lactobacillus rhamnosus GG is safe and well tolerated in adults and children with neurogenic lower urinary tract dysfunction: Firstinhuman trial. Ther Adv Urol. 2019;11:1756287219875594."},{"key":"b15","series-title":"J Am Geriatr Soc","first-page":"886887","article-title":"Continuous bladder irrigation with vancomycin for the treatment of methicillin resistant Staphylococcus aureus","volume":"44","author":"Hajjar RR","year":"1996","unstructured":"Hajjar RR, Philpot C, Morley JE. Continuous bladder irrigation with vancomycin for the treatment of methicillin resistant Staphylococcus aureus. J Am Geriatr Soc. 1996;44:886887."},{"key":"b16","series-title":"J Pediatr Pharmacol Ther","first-page":"102107","article-title":"Use of intravesicular amikacin irrigations for the treatment and prophylaxis of urinary tract infections in a patient with spina bifida and neurogenic bladder: A case report","volume":"16","author":"Huynh D","year":"2011","unstructured":"Huynh D, Morgan JA. Use of intravesicular amikacin irrigations for the treatment and prophylaxis of urinary tract infections in a patient with spina bifida and neurogenic bladder: A case report. J Pediatr Pharmacol Ther. 2011;16:102107."},{"key":"b17","series-title":"Br J Urol","first-page":"367374","article-title":"The value of kanamycincolistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord injury","volume":"51","author":"Pearman JW","year":"1979","unstructured":"Pearman JW. The value of kanamycincolistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord injury. Br J Urol. 1979;51:367374."},{"key":"b18","series-title":"Transl Androl Urol","first-page":"S163S170","article-title":"Recurrent urinary tract infections in patients with incomplete bladder emptying: Is there a role for intravesical therapy?","volume":"6","author":"Dray EV","year":"2017","unstructured":"Dray EV, Clemens JQ. Recurrent urinary tract infections in patients with incomplete bladder emptying: Is there a role for intravesical therapy? Transl Androl Urol. 2017;6:S163S170."},{"key":"b19","series-title":"Pediatr Surg Int","first-page":"781785","article-title":"Efficacy of bladder irrigation and surveillance program in prevention of urinary tract infections and bladder calculi in children with an ileocystoplasty and bladder neck repair","volume":"27","author":"Van Den Heijkant M","year":"2011","unstructured":"Van Den Heijkant M, Haider N, Taylor C, Subramaniam R. Efficacy of bladder irrigation and surveillance program in prevention of urinary tract infections and bladder calculi in children with an ileocystoplasty and bladder neck repair. Pediatr Surg Int. 2011;27:781785."},{"key":"b20","series-title":"Int J Antimicrob Agents","first-page":"485490","article-title":"Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation","volume":"36","author":"van Nieuwkoop C","year":"2010","unstructured":"van Nieuwkoop C, den Exter PL, Elzevier HW, den Hartigh J, van Dissel JT. Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation. Int J Antimicrob Agents. 2010;36:485490."},{"key":"b21","series-title":"J Urol","first-page":"18611864","article-title":"Safety of gentamicin bladder irrigations in complex urological cases","volume":"175","author":"Defoor W","year":"2006","unstructured":"Defoor W, et al. Safety of gentamicin bladder irrigations in complex urological cases. J Urol. 2006;175:18611864."},{"key":"b22","series-title":"J Urol","first-page":"549555","article-title":"Intravesical gentamicin treatment for recurrent urinary tract infections caused by multidrug resistant bacteria","volume":"201","author":"Stalenhoef JE","year":"2019","unstructured":"Stalenhoef JE, et al. Intravesical gentamicin treatment for recurrent urinary tract infections caused by multidrug resistant bacteria. J Urol. 2019;201:549555."},{"key":"b23","series-title":"Intravesical Administration of Therapeutic Medication for the Treatment of Bladder Cancer","author":"Baumbartner R","year":"2020","unstructured":"Baumbartner R, Chang S, Flick S, et al. Intravesical Administration of Therapeutic Medication for the Treatment of Bladder Cancer. 2020. https:\/\/www.auanet.org\/aboutus\/auastatements\/intravesicaladministrationoftherapeuticmedication."},{"key":"b24","series-title":"Spinal Cord Medicine","author":"Kirshblum SM","year":"2018","unstructured":"Kirshblum SM, Lin VW. Spinal Cord Medicine. 3rd ed. Springer; 2018."},{"key":"b25","series-title":"Indian J Urol","first-page":"8287","article-title":"The impact of anticholinergics on cognitive function in patients with neurogenic lower urinary tract dysfunction: A narrative review","volume":"40","author":"Welk B","year":"2024","unstructured":"Welk B. The impact of anticholinergics on cognitive function in patients with neurogenic lower urinary tract dysfunction: A narrative review. Indian J Urol. 2024;40:8287."},{"key":"b26","series-title":"Spinal Cord","first-page":"854861","article-title":"Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: A systematic review","volume":"60","author":"Akkoc Y","year":"2022","unstructured":"Akkoc Y. Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: A systematic review. Spinal Cord. 2022;60:854861."},{"key":"b27","series-title":"BJU Int","first-page":"2533","article-title":"Detrusor relaxing agents for neurogenic detrusor overactivity: A systematic review, metaanalysis and network metaanalysis","volume":"133","author":"Zhou Z","year":"2024","unstructured":"Zhou Z, Wang X, Li X, Liao L. Detrusor relaxing agents for neurogenic detrusor overactivity: A systematic review, metaanalysis and network metaanalysis. BJU Int. 2024;133:2533."},{"key":"b28","series-title":"Top Spinal Cord Inj Rehabil","first-page":"4457","article-title":"Intravesical Lactobacillus rhamnosus GG alters urobiome composition and diversity among people with neurogenic lower urinary tract dysfunction","volume":"29","author":"Groah SL","year":"2023","unstructured":"Groah SL, Rounds AK, P\u00e9rezLosada M. Intravesical Lactobacillus rhamnosus GG alters urobiome composition and diversity among people with neurogenic lower urinary tract dysfunction. Top Spinal Cord Inj Rehabil. 2023;29:4457."},{"key":"b29","series-title":"PM R","first-page":"229240","article-title":"Clinical profiles and symptom burden estimates to support decisionmaking using the urinary symptom questionnaire for people with neurogenic bladder (USQNB) using intermittent catheters","volume":"13","author":"Tractenberg RE","year":"2020","unstructured":"Tractenberg RE, et al. Clinical profiles and symptom burden estimates to support decisionmaking using the urinary symptom questionnaire for people with neurogenic bladder (USQNB) using intermittent catheters. PM R. 2020;13:229240."},{"issue":"7","key":"b30","series-title":"PM R","first-page":"695706","article-title":"Effects of intravesical Lactobacillus rhamnosus GG on urinary symptom burden in people with neurogenic lower urinary tract dysfunction","volume":"13","author":"Tractenberg RE","year":"2021","unstructured":"Tractenberg RE, et al. Effects of intravesical Lactobacillus rhamnosus GG on urinary symptom burden in people with neurogenic lower urinary tract dysfunction. PM R. 2021;13(7):695706. doi:10.1002\/pmrj.12470."},{"issue":"19","key":"b31","series-title":"J Bacteriol","article-title":"Phenyllactic acid is an active ingredientin bactericidal supernatants of Lactobacillus crispatus","volume":"203","author":"AbdulRahim O","year":"2021","unstructured":"AbdulRahim O, et al. Phenyllactic acid is an active ingredientin bactericidal supernatants of Lactobacillus crispatus. J Bacteriol. 2021;203(19):e0036021. doi:10.1128\/JB.0036021."},{"key":"b32","series-title":"Ther Adv Urol","first-page":"9199","article-title":"Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: An update on the evidence","volume":"8","author":"Lazzeri M","year":"2016","unstructured":"Lazzeri M, et al. Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: An update on the evidence. Ther Adv Urol. 2016;8:9199."},{"key":"b33","series-title":"J Spinal Cord Med","first-page":"830836","article-title":"Intravesical hyaluronic acid with chondroitin sulphate to prevent urinary tract infection after spinal cord injury","volume":"46","author":"King GK","year":"2023","unstructured":"King GK, et al. Intravesical hyaluronic acid with chondroitin sulphate to prevent urinary tract infection after spinal cord injury. J Spinal Cord Med. 2023;46:830836."},{"key":"b34","series-title":"Urology","first-page":"e48e57","article-title":"Current status of intravesical therapies for bladder pain syndrome (BPS): A narrative review of emerging evidence","volume":"156","author":"Jones P","year":"2021","unstructured":"Jones P, et al. Current status of intravesical therapies for bladder pain syndrome (BPS): A narrative review of emerging evidence. Urology. 2021;156:e48e57."},{"issue":"1960","key":"b35","series-title":"J Obstet Gynaecol Br Emp","first-page":"394401","article-title":"Urinary infection after colporrhaphy: Its incidence, causation and prevention","volume":"67","author":"Paterson ML","year":"1960","unstructured":"Paterson ML, Barr W, Macdonald S. Urinary infection after colporrhaphy: Its incidence, causation and prevention. J Obstet Gynaecol Br Emp. 1960;67:394401 (1960)."},{"key":"b36","series-title":"J Rehabil Med","first-page":"181184","article-title":"Bladder irrigation with Chlorhexidine reduces bacteriuria in persons with spinal cord injury","volume":"50","author":"Wikstr\u00f6m M","year":"2018","unstructured":"Wikstr\u00f6m M, Levi R, Antepohl W. Bladder irrigation with Chlorhexidine reduces bacteriuria in persons with spinal cord injury. J Rehabil Med. 2018;50:181184."},{"key":"b37","series-title":"Neurourol Urodyn","first-page":"6782","article-title":"Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta analysis. A report from the Neuro Urology Promotion Committee of the International Continence Society (ICS)","volume":"37","author":"Ph\u00e9 V","year":"2018","unstructured":"Ph\u00e9 V, et al. Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta analysis. A report from the Neuro Urology Promotion Committee of the International Continence Society (ICS). Neurourol Urodyn. 2018;37:6782."},{"key":"b38","series-title":"J Pediatr Urol","first-page":"366","article-title":"Intravesical hyaluronic acid treatment in recurrent urinary tract infections in children with spina bifida and neurogenic bladder","volume":"16","author":"Cicek N","year":"2020","unstructured":"Cicek N, Yildiz N, Alpay H. Intravesical hyaluronic acid treatment in recurrent urinary tract infections in children with spina bifida and neurogenic bladder. J Pediatr Urol. 2020;16:366.e1366.e5."},{"key":"b39","series-title":"Bladder Pain Syndrome","first-page":"307315","article-title":"Intravesical therapy","author":"Cervigni M","year":"2013","unstructured":"Cervigni M, Van Ophoven A. Intravesical therapy. In Nordling J, ed. Bladder Pain Syndrome. Springer; 2013:307315. doi:10.1007\/9781441969293_23."},{"key":"b40","series-title":"J Clin Med Res","first-page":"256260","article-title":"Longterm efficacy, safety, and tolerability of modified intravesical oxybutynin chloride for neurogenic bladder in children","volume":"11","author":"Honda M","year":"2019","unstructured":"Honda M, et al. Longterm efficacy, safety, and tolerability of modified intravesical oxybutynin chloride for neurogenic bladder in children. J Clin Med Res. 2019;11:256260."},{"key":"b41","series-title":"Int Urol Nephrol","first-page":"737747","article-title":"Intravesical oxybutynin therapy for patients with neurogenic detrusor overactivity: A systematic review and metaanalysis","volume":"54","author":"Shen S","year":"2022","unstructured":"Shen S, et al. Intravesical oxybutynin therapy for patients with neurogenic detrusor overactivity: A systematic review and metaanalysis. Int Urol Nephrol. 2022;54:737747."},{"key":"b42","series-title":"J Spinal Cord Med","first-page":"S6788","article-title":"Acute management of autonomic dysreflexia: Individuals with spinal cord injury presenting to healthcare facilities","volume":"25","author":"Consortium for Spinal Cord Medicine","year":"2002","unstructured":"Consortium for Spinal Cord Medicine. Acute management of autonomic dysreflexia: Individuals with spinal cord injury presenting to healthcare facilities. J Spinal Cord Med. 2002;25)Suppl 1): S6788."},{"key":"b43","series-title":"Br J Urol","first-page":"504507","article-title":"Treatment of interstitial cystitis with intravesical heparin","volume":"73","author":"Parsons CL","year":"1994","unstructured":"Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br J Urol. 1994;73:504507."},{"key":"b44","series-title":"J Formos Med Assoc","first-page":"309314","article-title":"Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis","volume":"100","author":"Kuo HC","year":"2001","unstructured":"Kuo HC. Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis. J Formos Med Assoc. 2001;100:309314."}],"container-title":["Topics in Spinal Cord Injury Rehabilitation"],"original-title":[],"link":[{"URL":"https:\/\/tscir.kglmeridian.com\/view\/journals\/tscr\/32\/1\/article-p21.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/tscir\/article-pdf\/32\/1\/21\/3550383\/i1945-5763-32-1-21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/tscir.kglmeridian.com\/downloadpdf\/journals\/tscr\/32\/1\/article-p21.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/tscir.kglmeridian.com\/downloadpdf\/journals\/tscr\/32\/1\/article-p21.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:51:03Z","timestamp":1775145063000},"score":1,"resource":{"primary":{"URL":"https:\/\/tscir.kglmeridian.com\/view\/journals\/tscr\/32\/1\/article-p21.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":88,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.46292\/sci24-00088","relation":{},"ISSN":["1082-0744","1945-5763"],"issn-type":[{"value":"1082-0744","type":"print"},{"value":"1945-5763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}